ATE496035T1 - Stickstoffenthaltende heterocyclische verbindungen - Google Patents
Stickstoffenthaltende heterocyclische verbindungenInfo
- Publication number
- ATE496035T1 ATE496035T1 AT99912061T AT99912061T ATE496035T1 AT E496035 T1 ATE496035 T1 AT E496035T1 AT 99912061 T AT99912061 T AT 99912061T AT 99912061 T AT99912061 T AT 99912061T AT E496035 T1 ATE496035 T1 AT E496035T1
- Authority
- AT
- Austria
- Prior art keywords
- atom
- substituted
- represent
- nitrogen
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8751498 | 1998-03-31 | ||
PCT/JP1999/001665 WO1999051582A1 (fr) | 1998-03-31 | 1999-03-31 | Composes heterocycliques azotes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE496035T1 true ATE496035T1 (de) | 2011-02-15 |
Family
ID=13917109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99912061T ATE496035T1 (de) | 1998-03-31 | 1999-03-31 | Stickstoffenthaltende heterocyclische verbindungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US6423716B1 (de) |
EP (1) | EP1067123B1 (de) |
AT (1) | ATE496035T1 (de) |
AU (1) | AU3053999A (de) |
CA (1) | CA2326324C (de) |
DE (1) | DE69943144D1 (de) |
ES (1) | ES2356886T3 (de) |
WO (1) | WO1999051582A1 (de) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001083456A1 (fr) * | 2000-04-27 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'heteroaryle condenses |
US6608053B2 (en) | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
US6723730B2 (en) | 2000-07-20 | 2004-04-20 | Neurogen Corporation | Capsaicin receptor ligands |
WO2002016361A2 (en) | 2000-08-18 | 2002-02-28 | Cor Therapeutics, Inc. | Nitrogenous heterocyclic compounds |
US6982266B2 (en) | 2000-08-18 | 2006-01-03 | Millennium Pharmaceuticals, Inc. | Quinazoline derivatives as kinase inhibitors |
EP1309569B1 (de) | 2000-08-18 | 2010-10-06 | Millennium Pharmaceuticals, Inc. | N-aryl-{4-[7-(alkoxy)Chinazolin-4-yl]Piperazinyl}Carboxamid-Verbindungen als PDGF-Rezeptoren Hemmer |
WO2002036587A2 (en) | 2000-11-01 | 2002-05-10 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
US20040259881A1 (en) * | 2001-02-02 | 2004-12-23 | Anjali Pandey | Nitrogenous heterocyclic compounds |
AU2002254152A1 (en) | 2001-03-08 | 2002-09-24 | Millennium Pharmaceuticals | (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
EP1373247A2 (de) * | 2001-03-29 | 2004-01-02 | Tanabe Seiyaku Co., Ltd. | Spirochinolinverbindungen, methode zu ihrer herstellung und zwischenprodukte |
JP2005503345A (ja) * | 2001-04-30 | 2005-02-03 | バイエル・コーポレーシヨン | 新規な4−アミノ−5,6−置換チオフェノ[2,3−d]ピリミジン |
IL160307A0 (en) | 2001-08-31 | 2004-07-25 | Univ Rockefeller | Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
US6845657B2 (en) * | 2002-03-28 | 2005-01-25 | Harrison R. Cooper Systems, Inc. | Apparatus for sampling drill hole cuttings |
EA200500114A1 (ru) * | 2002-06-28 | 2005-06-30 | Еуро-Селтик, С. А. | Терапевтические агенты, используемые для лечения боли |
US7262194B2 (en) * | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
US7157462B2 (en) * | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
US7488823B2 (en) | 2003-11-10 | 2009-02-10 | Array Biopharma, Inc. | Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
EP1567506A4 (de) * | 2002-11-20 | 2007-06-20 | Array Biopharma Inc | Cyanoguanidine und cyanoamidine als erbb2- und egfr-inhibitoren |
RU2006121990A (ru) * | 2003-11-21 | 2007-12-27 | Эррэй Биофарма Инк. (Us) | Ингибиторы протеинкиназ акт |
US7994172B2 (en) * | 2004-12-28 | 2011-08-09 | Exelixis, Inc. | [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases |
FR2880540B1 (fr) * | 2005-01-13 | 2008-07-11 | Aventis Pharma Sa | Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90 |
ES2645371T3 (es) | 2005-06-06 | 2017-12-05 | Intra-Cellular Therapies, Inc. | Compuestos orgánicos |
EP1919287A4 (de) * | 2005-08-23 | 2010-04-28 | Intra Cellular Therapies Inc | Organische verbindungen zur behandlung einer verringerten dopamin-rezeptorsignalisierungs-aktivität |
WO2007098214A1 (en) * | 2006-02-21 | 2007-08-30 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
CA2644850A1 (en) * | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
BRPI0710866A2 (pt) | 2006-04-26 | 2012-08-14 | Hoffmann La Roche | compostos farmacÊuticos |
CL2007001167A1 (es) * | 2006-04-26 | 2008-01-25 | Genentech Inc | Compuestos derivados de pirimidina condensada, inhibidores de p13-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicionfarmaceutica. |
US20080076924A1 (en) * | 2006-06-30 | 2008-03-27 | Patrick Betschmann | Piperazines as P2X7 antagonists |
CA2656364C (en) | 2006-07-06 | 2014-11-25 | Array Biopharma Inc. | Dihydrothieno pyrimidines as akt protein kinase inhibitors |
ATE523499T1 (de) * | 2006-07-06 | 2011-09-15 | Array Biopharma Inc | Cyclopenta [d]-pyrimidine als akt-proteinkinasehemmer |
DE602007011628D1 (de) | 2006-07-06 | 2011-02-10 | Array Biopharma Inc | Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren |
US8063050B2 (en) * | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
EP2081431B1 (de) * | 2006-11-13 | 2013-01-16 | Intra-Cellular Therapies, Inc. | Organische verbindungen |
WO2008070095A1 (en) | 2006-12-05 | 2008-06-12 | Intra-Cellular Therapies, Inc. | Novel uses |
CN101595100B (zh) | 2007-01-16 | 2014-06-11 | 普渡制药公司 | 作为orl-1配体的杂环取代的哌啶 |
US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
US8377937B2 (en) * | 2007-07-05 | 2013-02-19 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
TWI450720B (zh) | 2007-07-05 | 2014-09-01 | Array Biopharma Inc | 作為akt蛋白質激酶抑制劑之嘧啶環戊烷 |
EP3564240B1 (de) * | 2007-08-31 | 2022-04-06 | Purdue Pharma L.P. | Piperidinverbindungen als zwischenprodukte |
GB0721095D0 (en) * | 2007-10-26 | 2007-12-05 | Piramed Ltd | Pharmaceutical compounds |
US7946206B2 (en) * | 2007-11-21 | 2011-05-24 | Rocksmart, Llc | Quick-release system |
KR20100094551A (ko) * | 2007-12-06 | 2010-08-26 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
WO2009089352A1 (en) | 2008-01-08 | 2009-07-16 | Array Biopharma Inc. | Pyrrolopyridines as kinase inhibitors |
CN101965347B (zh) | 2008-01-09 | 2013-01-02 | 阵列生物制药公司 | 作为激酶抑制剂的吡唑并吡啶 |
AU2009204025B2 (en) * | 2008-01-09 | 2014-02-20 | Array Biopharma Inc. | Hydroxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
ES2401685T3 (es) * | 2008-01-09 | 2013-04-23 | Array Biopharma, Inc. | Pirimidil ciclopentano hidroxilado como inhibidor de la proteína quinasa AKT |
AU2009275218C1 (en) | 2008-07-21 | 2015-02-05 | Purdue Pharma L.P. | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds and the uses thereof |
US20100273808A1 (en) * | 2008-11-21 | 2010-10-28 | Millennium Pharmaceticals, Inc. | Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders |
EP2367431B1 (de) | 2008-12-06 | 2015-08-05 | Intra-Cellular Therapies, Inc. | Organische verbindungen |
BRPI0922809A2 (pt) | 2008-12-06 | 2018-05-29 | Intracellular Therapies Inc | compostos orgânicos |
SG171777A1 (en) | 2008-12-06 | 2011-07-28 | Intra Cellular Therapies Inc | Organic compounds |
US11464781B2 (en) | 2009-02-25 | 2022-10-11 | Intra-Cellular Therapies, Inc. | PDE1 inhibitors for ophthalmic disorders |
US9468637B2 (en) | 2009-05-13 | 2016-10-18 | Intra-Cellular Therapies, Inc. | Organic compounds |
SG10201507362TA (en) | 2009-08-05 | 2015-10-29 | Intra Cellular Therapies Inc | Novel Regulatory Proteins And Inhibitors |
US9371327B2 (en) | 2010-05-31 | 2016-06-21 | Intra-Cellular Therapies, Inc. | PDE1 inhibitor compounds |
US9434730B2 (en) | 2010-05-31 | 2016-09-06 | Intra-Cellular Therapies, Inc. | PDE1 inhibitor compounds |
TWI617560B (zh) * | 2010-09-14 | 2018-03-11 | 伊塞利克斯公司 | PI3Kδ 抑制劑以及其應用和生產方法 |
CN103874689B (zh) | 2011-04-01 | 2016-04-27 | 基因泰克公司 | Akt抑制剂化合物和威罗菲尼的组合及使用方法 |
CN103841976A (zh) | 2011-04-01 | 2014-06-04 | 基因泰克公司 | Akt和mek抑制剂化合物的组合及其使用方法 |
SG11201408700UA (en) * | 2012-06-28 | 2015-01-29 | Abbvie Inc | Cyanoguanidines and their use as antiviral agents |
WO2014086453A1 (en) * | 2012-12-07 | 2014-06-12 | Merck Patent Gmbh | Azaheterobicyclic compounds |
TR201809140T4 (tr) * | 2012-12-20 | 2018-07-23 | Katholieke Univ Leuven K U Leuven R&D | Terapötik olarak aktif pirazolo-pirimidin türevleri. |
USRE48622E1 (en) | 2012-12-20 | 2021-07-06 | UCB Biopharma SRL | Therapeutically active pyrazolo-pyrimidine derivatives |
US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
US9801882B2 (en) | 2013-02-17 | 2017-10-31 | Intra-Cellular Therapies, Inc. | Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases |
JP6437519B2 (ja) | 2013-03-15 | 2018-12-12 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
JP2016518343A (ja) | 2013-03-15 | 2016-06-23 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 新規使用 |
JP6810613B2 (ja) | 2014-06-20 | 2021-01-06 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
US10285992B2 (en) | 2014-08-07 | 2019-05-14 | Intra-Cellular Therapies, Inc. | Combinations of PDE1 inhibitors and NEP inhibitors and associated methods |
TWI686394B (zh) | 2014-08-07 | 2020-03-01 | 美商內胞醫療公司 | 有機化合物 |
US9546175B2 (en) | 2014-08-07 | 2017-01-17 | Intra-Cellular Therapies, Inc. | Organic compounds |
EP3725789B1 (de) | 2014-09-17 | 2022-03-09 | Intra-Cellular Therapies, Inc. | 7,8-dihydro-[2h]-imidazo-[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5h)-on-derivate als phosphodiesterase 1 (pde1) inhibitoren zur behandlung von erkrankungen, störungen oder verletzungen des zentralen nervensystems (zns) |
WO2017172795A1 (en) | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
EP3509589B1 (de) | 2016-09-12 | 2021-11-17 | Intra-Cellular Therapies, Inc. | Neuartige verwendungen |
US11839614B2 (en) | 2018-01-31 | 2023-12-12 | Intra-Cellular Therapies, Inc. | Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO128657B (de) * | 1966-10-31 | 1973-12-27 | Pfizer | |
US3723434A (en) | 1970-07-17 | 1973-03-27 | Pfizer | Piperazino isoquinoline bronchodilators |
SU474984A3 (ru) * | 1971-04-10 | 1975-06-25 | Д-Р Карл Томэ Гмбх (Фирма) | Способ получени пиридо (3,2- ) пиримидинов |
JPS58172379A (ja) * | 1982-04-02 | 1983-10-11 | Showa Denko Kk | 新規なキナゾリン誘導体 |
NZ225447A (en) | 1987-07-20 | 1991-12-23 | Merck & Co Inc | Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions |
DK0584222T3 (da) | 1991-05-10 | 1998-02-23 | Rhone Poulenc Rorer Int | Bis-mono- og bicycliske aryl- og heteroarylforbindelser, som inhiberer EGF- og/eller PDGF-receptor-tyrosinkinase |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
US5521184A (en) | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
JP3229693B2 (ja) * | 1993-02-22 | 2001-11-19 | 協和醗酵工業株式会社 | ピペラジン誘導体 |
US5656643A (en) | 1993-11-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
US5679683A (en) | 1994-01-25 | 1997-10-21 | Warner-Lambert Company | Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
DK0682027T3 (da) | 1994-05-03 | 1998-05-04 | Ciba Geigy Ag | Pyrrolopyrimidinderivater med antiproliferativ virkning |
GB9510757D0 (en) * | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
NZ304859A (en) | 1995-04-03 | 2000-01-28 | Novartis Ag | 4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives, medicaments and processes for the preparation thereof |
MX9709867A (es) | 1995-06-07 | 1998-03-31 | Pfizer | Derivados de pirimidina condensados con un anillo heterociclico, composiciones que contienen los mismos, y uso de los mismos. |
MX9800215A (es) | 1995-07-06 | 1998-03-31 | Novartis Ag | Pirrolopirimidas y procesos para su preparacion. |
AR004010A1 (es) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
US6143764A (en) | 1995-11-07 | 2000-11-07 | Kirin Beer Kabushiki Kaisha | Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same |
ES2177925T3 (es) | 1996-01-23 | 2002-12-16 | Novartis Ag | Pirrolopirimidinas y procedimientos para su preparacion. |
CA2239227C (en) * | 1996-10-01 | 2007-10-30 | Kenji Matsuno | Nitrogen-containing heterocyclic compounds |
-
1999
- 1999-03-31 EP EP99912061A patent/EP1067123B1/de not_active Expired - Lifetime
- 1999-03-31 DE DE69943144T patent/DE69943144D1/de not_active Expired - Lifetime
- 1999-03-31 ES ES99912061T patent/ES2356886T3/es not_active Expired - Lifetime
- 1999-03-31 WO PCT/JP1999/001665 patent/WO1999051582A1/ja active Application Filing
- 1999-03-31 US US09/647,490 patent/US6423716B1/en not_active Expired - Lifetime
- 1999-03-31 AT AT99912061T patent/ATE496035T1/de not_active IP Right Cessation
- 1999-03-31 AU AU30539/99A patent/AU3053999A/en not_active Abandoned
- 1999-03-31 CA CA2326324A patent/CA2326324C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2326324C (en) | 2010-05-11 |
EP1067123A4 (de) | 2002-04-03 |
ES2356886T3 (es) | 2011-04-14 |
EP1067123B1 (de) | 2011-01-19 |
DE69943144D1 (de) | 2011-03-03 |
EP1067123A1 (de) | 2001-01-10 |
WO1999051582A1 (fr) | 1999-10-14 |
CA2326324A1 (en) | 1999-10-14 |
AU3053999A (en) | 1999-10-25 |
US6423716B1 (en) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE496035T1 (de) | Stickstoffenthaltende heterocyclische verbindungen | |
NO953305D0 (no) | Antranilsyrederivat | |
EP1256574A4 (de) | Stickstoff-enthaltende verbindungen mit kinasehemmender wirkung sowie diese enthaltende medikamente | |
ATE480521T1 (de) | Stickstoff enthaltende heterocyclische verbindungen | |
ATE368655T1 (de) | Stickstoffhaltige heterocyclische verbindung und arzneimittel davon | |
CR7727A (es) | Compuestos quimicos | |
DE69428476D1 (de) | Heterocyclische Verbindungen als Bradykinin Antagonisten | |
DE60140860D1 (de) | 2-aminonicotinamid-derivate und ihre verwendung als vegf-rezeptor tyrosin-kinase inhibitoren | |
DK0976748T3 (da) | Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet | |
GR3006247T3 (de) | ||
ATE237612T1 (de) | Benzofuranderivate | |
WO2002028853A1 (fr) | Compose de benzylamine, son procede de production et produit intermediaire correspondant | |
CA2273303A1 (en) | Thienylsulfonylamino(thio)carbonyl compounds | |
PT1122253E (pt) | Derivados de quinazolinona | |
NO20053302L (no) | Imidazolderivater med affinitet for alfa 2-reseptoraktivitet. | |
DE69915471D1 (de) | Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
IL136510A (en) | Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same | |
DE60239324D1 (de) | Phenyl- und pyridyl-piperidine mit tnf-wirkung | |
TR199901102T2 (xx) | Bisiklik amin t�revleri. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |